for Good to I afternoon, formally and thank Vice to of as us. Investor this Matt opportunity Relations. our want you Bacso joining President take welcome new
For the I update, details Q&A. to a today's financial additional provide call followed opening the comments by we therapy. our the System. Growth compared of system performance and XXXX to Robotic data, representing $XX.X surgeon XXX% in AquaBeam patient base. the and hospital of long-term driven million, increased growth quarter the updated another will guidance our financial to quarter We drive who will our positive our benefits call, was from and XXXX. opening revenue pleased world was coverage the business with combination and by real XXXX provide outstanding patients Kevin, quarterly clinical once regarding of continue quarter sales report Total and of adoption results, are strong clinical to where third increased quarter for realize install utilization outcomes revenue Starting robotic again customers Aquablation interest believe payor and significant of to of third before continue primarily our
quarters, remain personnel material to experienced issues. potential to hospital current to capital and previous environment, equipment we Before not supply increase macro have product update, constraints meet mitigate to demand. spending. Furthermore, me Similar specifically, chain and address providing suppliers close to business vendors manufacturing supply the we any the briefly customer let continue and
with what in is and can our remain high customers on focused a way we supply quality we As we move into need timely. that they XXXX, ensuring
System Robotic positioned to for spending, factors stage our pertains sales due penetration. of around market capital our multitude it uniquely earlier and remain we analogy of momentum a our hospital to As AquaBeam continued positive around
visit men number many reason hospitals. is the one BPH high-volume men seeking urologists treatment a First, with option durable, at surgical
technologies other BPH due to System surgical increasing men educated safety Additionally, cutting alternatives. and competitive surgical cutting not the hospitals profile our forego to growing space. ensure offer many hospitals AquaBeam to technology allows stay hospitals. of lose and edge they current believe a to treatment With in patient a motivated We inferior are to of these patients investing area Robotic population, edge
XXXX Next, of installed total systems approximately an are surgeries, base which high-volume with performing we XXX of exited the X,XXX with of third XXX hospitals quarter targets. U.S. BPH
long in mitigate early with have very some also is patient optimize that the an with We these generally hospitals a target, reminder adequate liquidity of novel we important uncertain both associated front of adoption macro of historically have curve still BPH in to the technologies their factors are We runway prioritized and our believe offerings. treatment an us. environment. It risks high-volume
treat a monitor of now ability unique sizes are In summary, with their to macro environment coverage, on all of along choice. Aquablation than standardizing business. logical the continue AquaBeam's standardization, hospitals prostate, more This ever the impact treatment our we increased and insurance algorithm. make BPH shapes and given all aspects our Lastly, to
were comfortable However, forecast. not guidance we be our we with would increasing revenue not if our
our starting quarterly with organization. to business turning Now commercial updates,
growth field-based hiring strong with are earnings fourth quarter and Even our mentioned continue third expand further we plan confidence complete. XXXX, see to gives in track of to from a candidates, on high-quality our quarter tight labor As the team to market, which our commercial interest meeting us call, on objectives. which was and second our we in
Aquablation our function reps, focus to while reps reps’ sell drive to reminder, increase market penetration; and and sales educating increased to new field-based Aquablation is Capital capital training specialists. our utilization. sales clinical of support system a on surgeons reps, team As consists
ensure staff is function and surgical support excellent clinical support to outcome. and our experience patient Lastly, cases an
to into U.S. in penetrate regions, market commercial have outcome today. beyond our footprint currently hiring robust strong and we and our real-world the continue what XXXX Given further excellent to geographic plan new expand we field-based momentum, clinical pipeline, sales
support account, goal Aquablation XXXX reps sales coverage our base. we continue market will while expanding our training penetration, commercial Our relatively be capital will new given identifying, existing case new in to clinical low staff to team. add across the continue to surgeons educating to install Also, and facilitate and for our at
We on expect to late earnings provide further we detail when next our call February. our XXXX discuss outlook in
confident growth that we robust we will are XXXX allow continued, However, the XXXX. have exiting team in for
national Additionally, U.S. XX states. in Providence, multi-system, contract non-profit a across with health announced seven also hospitals September, with system we a
are as and in We Providence, In are hospital honored to to their other who Providence, committed advancing patient care growing programs to forward partner now health place with have systems supporting next-generation multiple networks. such innovation, we addition to leading integrated look with to large contracts
focused remain large access large with they hospital As on engaging to a IDNs and accelerate networks provide company, as process. the we sales
and comment trends utilization seen Next, I to have would we procedure like year-to-date. on
number quarter the increasing system of associated following hospital we believe to the from for population accounts. seeing are generally low System, continue factors, converted given TURP we utilization, AquaBeam meaningful, our most which majority at the performed cases, resective We sequential learning our predictability, BPH. volumes procedures PVP with utilization our and an believe each customers. reproducibility are of our and is increases Robotic the increasing to utilization seeing curve attributable are On procedure commonly the using are surgeons in We
receptive algorithm number increasing an their believe we result, procedure to standardize favor therapy. of of accounts a beginning are in As ablation
since experience a that size of independent prostate sizes. shape, outcomes range prostate using and Aquablation are clinical in data Additionally, surgeons our commercial broader of support are and therapy
XX are procedures January limitations standardize from to to data XX XXXX XX to surgeons due we most patients’ to milliliters, analyzing in surgical treated PVP to less when typically range performed Specifically, Aquablation and XXXX, September their Since are believe prevalent prostates milliliters. TURP alternatives. size beginning the of falls between than the
commenced operations. by to a Next, X, San around departments I a all square our we our move new timing July California. and XXX,XXX location in facilities quarter new into XXXX. wanted list our foot San third to of a standpoint, facility detail provide Jose On From expect the Jose, on we few
location we momentum curve, stage at XXXX experiencing our to production to adoption are of ensure current this plan smooth the quarter also Given growth our in through this the maintain capacity transition. at and we fourth
margin this we capacity expansion, expand critical long the our and to term limit gross investment operational are efficiency success. could making to are temporarily While
as We and today R&D are next will extremely expand footprint excited year manufacturing to much it have our by and more Jose lab. clean room complete our to move we San what house approximately robust a
BPA foreseeable future. target procedures, surgical standard for space With this give footprint us the anticipate of we becoming goal care of the enough for the will
provide plans. target payer on received coverage touching coverage Lastly, payer we population. quarter, percentage Shield of payers In and private Aquablation our in significant Medicare Blue coverage we updates, from the Cross estimate, third policy additional Horizon for a aggregate and other recent patient Blue
November high-volume expanding In by performance code to for shapes X, Hospital provide which execute each the finalized and APC Outpatient its Aquablation Prospective increasing our X.X% CMS coverage. procedure, for our rates. continue treating private year-to-date X strategic pleased and Payment of increase prostate approximate payer hospitals, approximately is will XXXX over plan Aquablation of summary, the we sizes BPH are $X,XXX The hospital an with full XXXX growth the on and penetrating utilization Additionally, Level range System.
to of that, our revolutionize this long-term turn I we With highlighting momentum believe call durability, over therapy will truly Kevin. clinical will and the Given data positive treatment Aquablation the BPH.
